Ceva Sante Animale

Sandrine Lacoste

Florence Guimberteau

Edouard Timsit

Hamadi Karembe

Laurence Peyrot

Benedicte Deminiere

Alexandra Beck

Claudio Zanichelli

Simona Binacchi

Cecilia Sacchetti

Marie-Laure Loubiere

Eliane Boivin

Romain Delcombel

The present invention relates to a nose ring for ruminants such as cattle, comprising a ring body () having an extra-nasal part () and intra-nasal parts () extending on either side of this extra-nasal part (), each of these intra-nasal parts () carrying a plate () intended to bear against the nasal septum separating the nasal cavities of a ruminant, said bearing plates () thus being placed at the ends of said nose ring. According to the invention, each bearing plate has an elongate shape and comprises opposite ends, at least one of which is wider than the central region thereof placed between said two ends, each plate being convex and having a front face intended to come into contact with the nasal wall of the animal, the surface area of which front face is at least equal to 500 mmand preferably at least equal to 1500 mm, and even more preferably at least equal to 2000 mm, each bearing plate thus being capable of maximising the contact surface with the nasal septum for different nasal morphologies in order to ensure that this ring is retained without injuring the animal.

Nose ring for ruminants

Nose ring for animals

The present invention relates to a veterinary or pharmaceutical composition comprising: (i) about 1-65% w/v of a pyrethroid, or a salt thereof, (ii) a macrocyclic lactone, or a salt thereof, (iii) at least one alkalizing agent, (iv) at least one non aqueous solvent, wherein the pH of the composition is comprised between about 6.5 and 8.5, when measured by adding 25% of water to an aliquot of said composition. The invention further relates to the use of such composition for preventing and/or treating parasites infestations.

Composition for treating parasites infestations

The present invention relates to a composition of less than or equal to about 1% of pheromones useful to treat or prevent a behavioral stress problem of a non-human mammal. It also relates to a device comprising said composition and to a method for preventing and/or treating stress-related behaviors in a non-human mammal, by using said composition or device.

Pheromone compositions and uses thereof

The invention relates to a composition containing pheromones comprising a carrier solvent, and to the use thereof for preventing and/or treating the behavioral or medical problems linked to the stress of non-human mammals. The invention also relates to a device for diffusing such a composition into the ambient air, and to a kit comprising said composition.

Compositions containing pheromones for treating behavioural or medical problems linked to the stress of non-human mammals

The invention relates to a liquid pharmaceutical composition, in the form of a suspension of micronized powder of active substance in an acceptable physiological liquid medium, stabilized over time, for administration via the oral route.

Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions

Mixture of fatty acids, their derivatives, ester or methyl ester derivates thereof, which may be administered to non-human mammals by diffusion in to ambient air during at least seven consecutive days, with a rapid kinetic of diffusion during the first three days of administration.

Methods of administering a mixture of fatty acids for the treatment of non-human mammals

Multi-layered plastic polymeric container useful for the storage and conservation of pharmaceutical compositions, sterile or non sterile, which comprises an inner layer and an outer layer, a gas barrier layer, and adhesive layers.

Growing community of inventors

Carignan de Bordeaux, France

Sandrine Lacoste